Scarica l'app Stockscreener
78.40
0.51%
0.40
Dopo l'orario di chiusura:
78.00
-0.40
-0.51%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$78.00
Aprire:
$77.61
Volume 24 ore:
2.46M
Relative Volume:
0.67
Capitalizzazione di mercato:
$30.74B
Reddito:
$4.30B
Utile/perdita netta:
$571.50M
Rapporto P/E:
54.44
EPS:
1.44
Flusso di cassa netto:
$570.80M
1 W Prestazione:
+5.52%
1M Prestazione:
-0.58%
6M Prestazione:
+0.72%
1 anno Prestazione:
+12.47%
Intervallo 1D:
$77.61
$79.20
Intervallo di 1 settimana:
$74.00
$81.64
Portata 52W:
$57.52
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Nome
Dexcom Inc
Settore
Industria
Telefono
(858) 200-0200
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Confronta DXCM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
78.40 | 30.59B | 4.30B | 571.50M | 570.80M | 1.44 |
|
ABT
Abbott Laboratories
|
131.95 | 230.09B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
108.09 | 160.24B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.76 | 150.29B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.07 | 119.28B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
79.80 | 47.09B | 5.69B | 1.41B | 577.90M | 6.95 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-21 | Iniziato | Argus | Buy |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-02-03 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Iniziato | Redburn Atlantic | Neutral |
| 2024-03-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-01-26 | Iniziato | Wolfe Research | Outperform |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-15 | Iniziato | Bernstein | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-18 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2021-01-06 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Reiterato | Piper Sandler | Overweight |
| 2020-05-14 | Iniziato | Wells Fargo | Equal Weight |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-11-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-10-23 | Iniziato | Stifel | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-09-12 | Aggiornamento | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Reiterato | Canaccord Genuity | Buy |
| 2018-07-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
| 2018-05-03 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-04 | Iniziato | Goldman | Sell |
| 2018-04-04 | Iniziato | Guggenheim | Neutral |
| 2018-03-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Downgrade | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Reiterato | Wedbush | Outperform |
Mostra tutto
Dexcom Inc Borsa (DXCM) Ultime notizie
After 30 years, Vancouver Ad Agency Wasserman Unveils New Identity as 9Letters - GlobeNewswire Inc.
AQR Capital Management LLC Raises Stake in DexCom, Inc. $DXCM - MarketBeat
DexCom (NASDAQ:DXCM) Trading Up 6.2%Should You Buy? - MarketBeat
How Is DexCom's Performance Compared to Other Medical Device Companies? - MSN
DexCom Faces Organic Issues, Competition Threat Despite 'Doing Everything' to Topple Headwinds, Oppenheimer Says - MarketScreener
Why DexCom (DXCM) Shares Are Sliding Today - Yahoo Finance
Oppenheimer Downgrades DexCom to Perform From Outperform, Removes $102 Price Target - MarketScreener
Can Traders Expect Breakout From DexCom Inc. This WeekWeekly Gains Report & Free Safe Capital Growth Stock Tips - beatles.ru
What is DexCom Inc. s P E ratio telling us2025 Price Targets & Pattern Based Trade Signal System - beatles.ru
Buyback Watch: Can DexCom Inc. benefit from deglobalizationQuarterly Trade Summary & Growth Oriented Trade Recommendations - 강소기업뉴스
Should I average down on DexCom Inc. stock2025 Biggest Moves & Fast Moving Stock Trade Plans - خودرو بانک
DexCom Faces Evaluation Adjustment Amid Strong Financial Performance and Quality Concerns - Markets Mojo
What the charts say about DexCom Inc. todayJuly 2025 Analyst Calls & Low Risk Investment Opportunities - Newser
Can trapped investors hope for a rebound in DexCom Inc.Day Trade & Technical Pattern Based Signals - Newser
What recovery options are there for DexCom Inc.Market Risk Analysis & Accurate Entry and Exit Point Alerts - Newser
What momentum shifts mean for DexCom Inc.Portfolio Update Report & Free Expert Verified Stock Movement Alerts - Newser
Using RSI to spot recovery in DexCom Inc.Earnings Recap Report & Smart Money Movement Tracker - Newser
Analyzing DexCom Inc. with risk reward ratio chartsBull Run & Safe Capital Growth Stock Tips - Newser
Ranking DexCom Inc. among high performing stocks via toolsWeekly Gains Summary & Real-Time Volume Spike Alerts - Newser
Using data filters to optimize entry into DexCom Inc.July 2025 Drop Watch & Reliable Price Breakout Alerts - Newser
How to monitor DexCom Inc. with trend dashboardsOptions Play & AI Powered Market Entry Strategies - Newser
Dexcom shares fall 1.19% after-hours as insider sells $357,796 worth of shares. - AInvest
Assessing the Impact of Insider Share Sales on Investor Confidence in Dexcom (DXCM) - AInvest
Dealogic: DEXCOM INC EVP Jereme Sells 4824 Shares at $74.17/Share on 2025-09-02 - AInvest
Dexcom to lay off about 350 people - MedTech Dive
Why DexCom (DXCM) Stock Is Up Today - Yahoo Finance
Will DexCom Inc. outperform tech stocks2025 Volatility Report & Capital Efficiency Focused Ideas - خودرو بانک
Dexcom, Inc. shares rise 3.35% intraday after positive presentation at Wells Fargo 20th. - AInvest
Understanding DexCom Inc.’s price movementGap Down & Risk Adjusted Buy and Sell Alerts - Newser
Market reaction to DexCom Inc.’s recent newsPortfolio Risk Report & AI Driven Price Forecasts - Newser
Applying Wyckoff theory to DexCom Inc. stockWeekly Stock Analysis & Verified Chart Pattern Signals - Newser
Signal strength of DexCom Inc. stock in tech scannersJuly 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
Is DexCom Inc. backed by strong institutional buyingDollar Strength & Real-Time Sentiment Analysis - خودرو بانک
Calif. biotech company Dexcom lays off hundreds amid shift to Arizona - SFGATE
DexCom at Wells Fargo Conference: Strategic Growth Plans - Investing.com
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Transcript : DexCom, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-03-2025 02 - MarketScreener
Dexcom shares jump, up 4.9%, a session high - AInvest
What data driven models say about DexCom Inc.’s future2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-03 08:54:41 - Newser
How to recover losses in DexCom Inc. stockWeekly Market Report & Comprehensive Market Scan Reports - Newser
Will DexCom's (DXCM) Latest Investor Update Hint at a Shifting Innovation Strategy? - simplywall.st
Analyzing drawdowns of DexCom Inc. with statistical toolsTrade Risk Assessment & High Conviction Buy Zone Alerts - Newser
Custom watchlist performance reports with DexCom Inc.July 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser
Tools to assess DexCom Inc.’s risk profileWeekly Profit Summary & Safe Entry Trade Reports - Newser
What candlestick patterns are forming on DexCom Inc.2025 Institutional Moves & Weekly Breakout Watchlists - Newser
Exit strategy if you’re trapped in DexCom Inc.July 2025 Analyst Calls & Daily Stock Trend Watchlist - Newser
Published on: 2025-09-03 23:05:34 - Newser
Custom watchlist performance reports with DexCom IncMarket Performance Report & Fast Moving Stock Watchlists - Newser
Stock Analysis | Dexcom OutlookWeak Technicals and Mixed Analyst Sentiment - AInvest
Should you hold or exit DexCom Inc. nowTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser
Dexcom Inc Azioni (DXCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.01%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):